Potassium Channel Tetramerisation Domain Containing 17 (KCTD17) (Middle Region) Peptide
Quick Overview for Potassium Channel Tetramerisation Domain Containing 17 (KCTD17) (Middle Region) Peptide (ABIN8108611)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- KCTD17 Peptide - middle region
-
Sequence
- DQAEFLCVVS KELHSTPNGL SSESSRKTKS TEEQLEEQQQ QEEEVEEVEV
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti- KCTD17 Antibody (ARP86452_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- KCTD17 (Potassium Channel Tetramerisation Domain Containing 17 (KCTD17))
-
Background
- Is a positive regulator of ciliogenesis, playing a crucial role in the initial steps of axoneme extension. It acts as a substrate-adapter for CUL3-RING ubiquitin ligase complexes which mediate the ubiquitination and subsequent proteasomal degradation of TCHP, a protein involved in ciliogenesis down-regulation. May be involved in endoplasmic reticulum calcium ion homeostasis.
-
Molecular Weight
- 35 kDa
-
Gene ID
- 79734
-
NCBI Accession
- NP_001269613
-
UniProt
- Q8N5Z5
Target
-